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Questions remain about quality of life after
abdominal aortic aneurysm repair
George Peach, MRCS, Peter Holt, PhD, FRCS, Ian Loftus, MD, FRCS,
Matt M. Thompson, MD, FRCS, and Robert Hinchliffe, MD, FRCS, London, United Kingdom
Introduction: Morbidity and mortality have traditionally been used as key markers of surgical outcome. However, as
complication rates associated with abdominal aortic aneurysm (AAA) repair decrease, subjective measures, such as quality
of life (QOL), are increasingly recognized as important indicators of treatment efficacy and quality of care. This review
presents the existing evidence relating to QOL changes in patients undergoing AAA repair by open repair (OR) and
endovascular techniques (EVAR) and challenges current misconceptions about the relative effect of these two procedures.
Methods: A comprehensive literature search was performed to identify studies relating to QOL or health status in AAA
repair. Quality of included studies was assessed according to Scottish Intercollegiate Guidelines Network methodology.
Results: Twenty-three studies satisfied the inclusion criteria. Preoperative QOL in AAA patients has been previously
suggested as being worse than that of the general population, that OR patients have a worse QOL in the early
postoperative period, and that EVAR patients have a worse QOL in the longer term. None of these assertions is uniformly
supported in the literature. From the existing evidence, no clear conclusions can be drawn about the relative QOL benefits
of OR vs EVAR.
Conclusions: There are a paucity of good-quality data relating to health status and QOL in patients undergoing AAA
repair. Little is known about the prevalence of preoperative or postoperative symptoms and the degree to which these
influence patient well-being. Further investigation is needed to clarify health status and QOL changes in these patients
and allow clinicians to make targeted improvements in practice. ( J Vasc Surg 2012;56:520-7.)
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bFor many years, morbidity and mortality have been
considered the key markers of surgical outcome and have
routinely been used to assess performance and evaluate new
procedures. With continuing efforts to achieve patient-
centered health care, however, it has become apparent that
more subjective measures, such as quality of life (QOL),
health status (HS), and patient satisfaction (PS) are also of
considerable importance.
These concepts are increasingly relevant in abdominal
aortic aneurysm (AAA) repair. During the last 2 decades,
there have been significant improvements in perioperative
care and in surgical technique, with a progressive shift from
open repair (OR) to endovascular aneurysm repair
(EVAR). These factors have led to a marked reduction in
the number of early complications and deaths associated
with aneurysm repair, and 30-day mortality is now 2% in
some centers.
The falling mortality rate means that death may be-
come a less discriminatorymeasure of patient outcome than
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520reviously, so additional indicators must be sought. Equally
mportant, measurement of HS, QOL, and PS allows iden-
ification of deficiencies in care from the patient’s perspec-
ive. Clinicians can then target those issues or symptoms
hat are most important to patients and strive for even
igher quality care rather than simply avoiding adverse
utcomes such as death and morbidity.
QOL,HS, and PS are assessed using patient-completed
uestionnaires that typically include aspects of physical and
sychologic well-being but may also incorporate cognitive,
ocial, sexual, or emotional function.1-3 Questionnaires
ay be generic, allowing comparison of results from differ-
nt conditions, or disease-specific, providing greater infor-
ation on the condition in question but preventing com-
arison between conditions. In the absence of an appropriate
isease-specific measure, all previous studies of QOL in
atients undergoing aneurysm repair have used generic
ools, such as the Medical Outcomes Study 36-Item Short
orm Health Survey (SF-36), or variations of this assess-
ent, and the EuroQol-5D (EQ-5D).4,5 Although often
resented as measures of QOL or health-related quality of
ife (HRQOL), these tools actually measure HS (ie, physi-
al and mental function) rather than QOL, which is a much
roader concept relating to how physical or mental dys-
unction affects patients’ lives. This review will therefore
efer to HS hereafter, although “quality of life” is retained
n the title for ease of identification.
This review synthesizes the existing evidence relating to
S changes in patients undergoing AAA repair by EVAR
nd OR and assesses the notion that EVAR patients have
etter short-term QOL whereas OR patients have better
ong-term QOL.
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Literature search. A comprehensive literature search
was performed according to Preferred Reporting Items for
Systematic Reviews and Meta-analyses (PRISMA) guide-
lines6 usingMedline, ExcerptaMedica Database (EMBASE),
and The Cochrane Database to identify relevant articles
published in English between 1950 and 2011 (last search
date was Feb 21, 2012). Search terms (keyword/MeSH)
included quality of life; health status; patient reported out-
come; PROM; and aortic aneurysm, abdominal; aneurysm
repair; endovascular aneurysm repair; and EVAR. Bibliog-
raphies of identified articles were reviewed to identify fur-
ther relevant studies.
Inclusion and exclusion criteria. All studies present-
ing data on perioperative or postoperative QOL or HS in
elective AAA repair were considered for inclusion. Studies
that dealt solely with screening or preoperative QOL were
excluded, as were those relating to repair of ruptured AAA,
thoracic aneurysms, aortic dissection, or other aortic pa-
thology. Studies were also excluded if they used unvali-
dated measurement tools to assess QOL/HS (irrespective
of whether these were disease-specific or generic), because
such tools do not yield reproducible/valid results. Review
articles, letters, comments, and conference abstracts were
excluded (Fig).
Assessment of quality. The quality of the studies
included in the final analysis was assessed according to
 946 papers identiied using keyword / 
subject search 
   881 papers excluded as 
duplicate or not relevant to HS 
or QoL in AAA
65 studies assessed in detail
A further 42 studies excluded:
- 7 review 
- 4 used unvalidated tools 
- 3 related to screening only 
- 1 gave no discrete QoL/HS 
data 
- 12 letter/editorial/abstract 
- 11 not directly related to 
AAA or QoL/HS 
- 1 assessed tool not QoL/HS 
- 3 not English language 
23 included in inal analysis
Fig. Diagram shows study selection according to Preferred Re-
porting Items for Systematic Reviews and Meta-Analyses
(PRIMAS). AAA, Abdominal aortic aneurysm; HS, health status;
QOL, quality of life.Scottish Intercollegiate Guidelines Network (SIGN)meth- rdology7 (Appendix 1, online only), and each study was
ssigned a score indicating the level of evidence (Table I).
ssessment was made in relation to the overall quality of
ach study rather than in relation to the quality of HS data
resented.
ESULTS
The search strategy identified 946 articles, of which
81 were excluded after a title and abstract review (most
aving been related to other aortic pathologies or aortic
alve disease). We assessed 65 studies in detail and a further
2 excluded (Fig); therefore, the final review analyzed 23
tudies. Meta-analysis was not appropriate due to the het-
rogeneity of the data and a systematic review was therefore
ndertaken.
Study characteristics. Of the studies analyzed in this
eview, nine were randomized controlled trials (RCT),8-16
ine were prospective cohort studies,17-25 and five were
urely retrospective or cross-sectional in design.26-30 Ten
f the prospective studies reported HS as a primary end
oint (with only one of these being an RCT),12,17-25 with
ll other prospective trials assessing HS as a secondary end
oint only.8-11,13-15 Most studies included EVAR and OR
atients, although these groups were not always well
atched. Four studies involved EVAR as the only interven-
ion,8,11,16 and five included only OR patients.23,24
he SF-36 was used in 16 studies to measure
S,8-12,14-18,20,21,23-26 six used EQ-5D (in isolation or
longside another measure),8-10,12,14,27 two used the Not-
ingham Health Profile (NHP),22,28 and two used the SF
2-item survey.19,27,31 Other measurement tools were only
sed in single studies (Table I).
Preoperative HS. None of the studies reported any
tatistical difference between overall HS scores in EVAR
nd OR groups preoperatively (Table II). This finding was
rrespective of whether differences were assessed before or
fter randomization in the RCTs or between cohorts in the
onrandomized studies.
Several studies compared preoperative HS with that of
n age-matched general population using the SF-36. Al-
hough three of these found no significant difference be-
ween these groups,9,14,17 Aquino et al18 found patients
waiting intervention had a better HS than an age-matched
eneral population, whereas Mangione et al23 found the
S of preoperative patients was worse. Preoperative base-
ine scores were significantly worse in the United Kingdom
ndovascular Aneurysm Repair 2 (EVAR2) trial than in
nited KingdomEndovascular Aneurysm 1 (EVAR1) trial,
ut this was unsurprising because this cohort of patients
as specifically deemed unfit for OR.
Early postoperative period. HS scores fell signifi-
antly in EVAR and OR groups during the first few weeks
fter aneurysm repair, although the relative effect of the two
rocedures varied between studies. Some found that OR
nd EVAR affected HS to the same degree,17,19,22 but
everal authors demonstrated significant differences be-
ween the two groups. Aljabri et al17 and Soulez et al15eported significantly worse pain and general health after
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August 2012522 Peach et alEVAR than after OR, even 3 to 4 weeks postintervention.
In contrast, two groups found that HS had returned to
preoperative levels by 4 weeks after intervention in the
EVAR group,18,20 whereas the OR group was still signifi-
cantly worse than baseline.
Most of the studies that examined HS at 2 to 3 months
after intervention found that all scores had returned to
baseline level or better in both groups, although this was
not supported by longer-term outcomes reported by other
authors. Most found no significant difference between OR
and EVAR; however, these were predominantly small, low-
quality studies, and the risk of a type 2 statistical error was
therefore high. Conversely, Aquino et al18 showed HS had
improved more in EVAR patients (role physical domain),
whereas Prinssen et al14 found HS was better in the OR
group (general health and mental health).12,15,20,22,24
The EVAR1 and EVAR2 trials and the study by Vogel
et al25 suggested there was still a significant drop in HS
scores for both groups during this stage, but their measure-
ments were taken during the broad 0- to 3-month period
rather than at specific intervals.8,9
HS at 4 to 6 months postintervention. Many of the
Table I. Study characteristics
Author Pts (No.) EVAR (No.)
Al Jabri,17 2006 76 43
Aquino,18 2001 51 25
Ballard,19 2004 129 22
De Rango,16 2011 360 182
Dick,26 2008 401 68
Ehlers,27 2011 328 0
EVAR1,9 2005 1082 543
EVAR2,8 2005 338 192
Jones,20 2002 51 26
Kurz,28 2010 45 45
Lederle,10 2009 881 444
Lederle,11 2003 1136 569
Lloyd,21 2000 82 24
Lottman,12 2004 76 57
Magee,29 1992 131 Nil
Malina,22 2000 40 20
Mangione,23 1997 95 0
Perkins,24 1998 59 0
Prinssen,14 2004 153 78
Sandstrom,30 1996 42 0
Soulez,15 2005 40 20
UKSAT,13 1998 1090 12 (515 surveillance)
Vogel,25 2005 218 126
EQ-5D, EuroQol 5-D; EQ-VAS, EuroQol Visual Analog Scale; EVAR, en
Repair 1 trial; EVAR2, United Kingdom Endovascular Aneurysm Repair 2
Examination;NHP,NottinghamHealth Profile;OR, open repair;RCT, ran
(12-item, 20-item, 36-item) Health Survey; QOL, quality of life; TEA, Test
aScottish Intercollegiate Guidelines Network (SIGN) level of evidence (LOEstudies that assessed HS during this period showed that HS acores were at preoperative levels or better by this
oint.14,19,23-25 Though most did not find any significant
ifference between OR and EVAR groups, Prinssen et al14
eported that scores in the OR group showed greater
mprovement above baseline than those in the EVAR
roup. Furthermore, Aljabri et al17 showed that although
he OR and EVAR scores were not significantly different
rom baseline, absolute HS scores were significantly higher
n the OR group than in the EVAR group (in six of eight
omains).17 It should be noted, however, that two of the
tudies that assessed HS at this interval included only OR
atients and no comparison could be made between
roups.
In contrast, however, two groups found HS was worse
t 6 months than it had been preoperatively: Lloyd et al21
howed that vitality, physical function, and cognitive func-
ion were significantly below baseline in both OR and
VAR groups, but the EVAR group had worse pain and
eneral health (nonsignificant). Soulez et al15 found there
as a gradual decline in QOL for both groups across all
F-36 domains from 3 months onward.
In their comparison of QOL during surveillance and
OR (No.) Trial name Study type
33 / Prospective cohort
26 / Prospective cohort
107 / Prospective cohort
(178 surveillance) CAESAR RCT
244 / Retrospective cohort
328 / Cross-sectional
539 EVAR1 RCT
(146 surveillance) EVAR2 RCT
25 / Prospective cohort
Nil / Cross-sectional
437 / RCT
il (567 surveillance) ADAM RCT
40 / Prospective cohort
19 / RCT
86 / Cross-sectional
20 / Prospective cohort
95 / Prospective cohort
59 / Prospective cohort
75 DREAM RCT
42 / Cross-sectional
20 / RCT
563 UKSAT RCT
92 / Prospective cohort
ular aneurysm repair; EVAR1, United Kingdom Endovascular Aneurysm
IIEF, International Index of Erectile Function; MMSE, Mini-Mental State
ed controlled trial; SF-12,20,36,Medical Outcomes Study Short Form
eryday Attention; UKSAT, United Kingdom Small Aneurysm Trial.
overall quality of study.0
0
N
dovasc
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domizfter EVAR, De Rango et al16 showed that SF-36 scores for
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Volume 56, Number 2 Peach et al 523patients who had undergone EVAR were significantly bet-
ter than at baseline, whereas scores were worse than base-
line for those under surveillance, particularly in relation to
physical function and bodily pain. Lederle et al11 also found
that EVAR patients had better general health scores than
surveillance patients at 6 months but that surveillance pa-
tients had better vitality scores by this point.
More than 1 year after intervention. At 1 year
postintervention, Ballard et al19 found that all scores in
both OR and EVAR groups were equal to baseline levels, as
they had been at 4 months. However, this study included
only 22 EVAR patients vs 129 OR patients and was not
explicit about late complication rates. They may, therefore,
have failed to show the true effect of any reintervention
after EVAR. Mangione et al23 recorded even more positive
results in their cohort of OR patients and showed that some
domain scores (role physical, mental health, and role emo-
tional) were significantly better at 1 year than they had been
preoperatively. Although Aquino et al18 found OR scores
were the same as baseline, they also found that it was the
EVAR patients who showed significant improvement, spe-
cifically in physical function. Lederle et al10 found no
Table I. Continued.
Author QOL tool(s) used
QOL 1st or
2nd end poin
Al Jabri,17 2006 SF-36 1
Aquino,18 2001 SF-36 1
Ballard,19 2004 SF-12 1
De Rango,16 2011 SF-36 2
Dick,26 2008 SF-36 1
Ehlers,27 2011 EQ-5D, EQ-VAS, SF-12 1
EVAR1,9 2005 SF-36, EQ-5D 2
EVAR2,8 2005 SF-36, EQ-5D 2
Jones,20 2002 SF-36 1
Kurz,28 2010 NHP 1
Lederle,10 2009 SF-36. EQ-5D, IIEF-5 2
Lederle,11 2003 SF-36 2
Lloyd,21 2000 SF-36, MMSE, TEA 1
Lottman,12 2004 SF-36/EQ-5D 1
Magee,29 1992 Rosser Index 1
Malina,22 2000 NHP 1
Mangione,23 1997 SF-36 1
Perkins,24 1998 SF-36/York QOL 1
Prinssen,14 2004 SF-36 and EQ-5D 2
Sandstrom,30 1996 SIP and Health Index 1
Soulez,15 2005 Kasrnofsky and SF-36 2
UKSAT,13 1998 SF-20 2
Vogel,25 2005 SF-36 1significant difference between OR and EVAR groups at 1 pear but did not comment on change in either group
elative to baseline. Vogel et al25 also commented that
-year scores were the same as baseline, but once again,
heir results were recorded in the period from 3 to 12
onths rather than specifically at 12 months.
In contrast to these reported improvements, Soulez et
l15 showed a continuation of the steady decline in HS that
hey had observed since 6 months after the intervention.
urthermore, although Prinssen et al14 demonstrated that
motional and mental health had improved relative to
reoperative scores, they also found that physical function
cores in the EVAR group were significantly worse than
reoperatively.
At 1 year, Lederle et al11 found that general health was
etter in the group who had undergone EVAR than in a
urveillance group, but vitality was better in the surveillance
ohort. Similar findings were reported for OR patients in
he United Kingdom Small Aneurysm Trial (UKSAT)
tudy, which showed that those who had undergone OR
ad improved perception of health and less pain than
atients under surveillance.13 However, beyond 1 year
Pre-op measurement
(Yes/No) Post-op timing of measure
SIGN
LOE a
Yes 1 week, 1 month, 6 months 2
Yes 1, 4, 8 weeks, 1 year 2–
Yes 3 weeks, 4 months, 1 year 2
Yes (before
randomization)
6 months, then every 12
months
1
No Once at 58 months (mean) 2–
No Once at 60 months (mean) 2–
Yes 0-3, 3-12, 12-24 months 1
Yes 0-3, 3-12, 12-24 months 1
Yes 1, 4, 8 weeks 2
No Once at 34-55 months 2–
Yes 1 year, 2 years 1
Yes (after
randomization)
Every 6 months up to 8 years
post-op
1
Yes 6 months 2
Yes 1 month, 3 months 1
No Once at 30 months (mean) 2–
Yes 5, 30, 90 days 2–
Yes 1, 6, 12 months 2–
Yes 6 weeks, 3 months, 6 months 2–
Yes 3 and 6 weeks, 3, 6, and 12
months
1
No Once at 6-12 months 2–
Yes 1, 3, 6, 12 months 1
Yes (before
randomization)
Every 3-6 months during
surveillance; every 3-6
months for 1 year post-op
1
Yes 2 weeks-3 months, 3-12
months
2–tostintervention, De Rango et al found SF-36 scores were
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August 2012524 Peach et alsignificantly below baseline in both EVAR and surveillance
groups.
None of the studies that assessed HS 1 year postop-
eratively found any significant difference between EVAR
and OR groups or any difference in HS scores relative to
baseline.8,9,11,26,29
DISCUSSION
The evidence presented shows that there is still signifi-
cant disagreement about the nature and timing of HS
changes associated with AAA surveillance and AAA repair.
It has previously been suggested that preoperative QOL is
worse than that of the general population,30,32 that OR
patients have a worse QOL in the early postoperative
period, and that EVAR patients have a worse QOL in the
longer term. None of these assertions is uniformly sup-
ported in the literature.
Is health status worse amongst AAA patients than
in the general population? None of the studies found any
difference in overall HS between EVAR and OR patients
preoperatively. There were, however, discrepancies in rela-
tion to HS of patients with AAA compared with that of the
general population. Although the general burden of cardio-
vascular disease may have an adverse effect on HS in these
Table II. Changes in health status (HS) over time
First author HS tool used
Pre-opa
EVAR OR
Aljabri,17 2006 SF-36 ↔ ↔
Aquino,18 2001 SF-36 1 1
Ballard,19 2004 SF-12 . . . . . .
De Rango,16 2011 SF-36 . . . . . .
EVAR1,9 2005 SF-36, EQ-5D ↔ ↔
EVAR2,8 2005 SF-36, EQ-5D . . . . . .
Jones,20 2001 SF-36 . . . . . .
Lederle,10 2009 SF-36, EQ-5D, IIEF-5 . . . . . .
Lederle,11 2003 SF-36 . . . . . .
Lloyd,21 2000 SF-36, MMSE . . . . . .
Lottman,12 2004 SF-36, EQ-5D . . . . . .
Malina,22 2000 NHP . . . . . .
Mangione,23 1997 SF-36 . . . 2
Perkins,24 1998 SF-36, York QOL . . . . . .
Prinssen,14 2004 SF-36, EQ-5D ↔ ↔
Soulez,15 2005 SF-36, Karnofsky . . . . . .
UKSAT,13 1998 SF-20 . . . . . .
Vogel,25 2005 SF-36 . . . . . .
1, Health status significantly better than baseline;2, health status signific
some domains worse;↔, health status not significantly different from baselin
IIEF, International Index of Erectile Function; MMSE, Mini-Mental State
collection; OR, open repair; QOL, quality of life; SF-12,20,36,Medical
surveillance; UKSAT, United Kingdom Small Aneurysm Trial.
aResults (where shown) relative to general population.
bIndicated change significantly greater in this procedure.
cNeither group significantly different from baseline but OR scores significan
dResult for surveillance not OR/EVAR, but no comment relative to baselin
eNo significant difference between EVAR and OR, but no comment relativ
fBoth significantly below baseline (general health affected more in surveillan
gGradual decline in scores. Level of significance not given.patients, it is possible that once a patient is diagnosed with rAA, the knowledge of this life-threatening condition may
dversely affect the patient’s QOL. This is a view supported
y Mangione et al,23 who found that before intervention,
atients had significantly worse scores formental health and
ole emotional than members of the general population.
owever, they also found that role physical was adversely
ffected in these patients before intervention, suggesting
hat there may be other underlying influences. Further-
ore, several studies (including the large EVAR1 study)
ound that HS scores were the same in preintervention
atients as in the general population, challenging the prop-
sition that HS is adversely affected by knowledge of the
ondition. Indeed, Aquino et al18 found HS was better in
he preoperative cohort than in the general population,
lthough this was a small study and may have suffered from
election bias because they did not interview consecutive
atients.
Does OR affect HS more than EVAR in the early
ostoperative period? Although two of the higher-
uality studies concluded that health status was worse after
R than after EVAR in the first few weeks postinterven-
ion,12,14 there were those who found EVAR had as much
f not more negative effect on HS at this assessment,
articularly in relation to pain and physical function. The
-2 weeks 3-4 weeks 6 weeks 8 weeks
AR OR EVAR OR EVAR OR EVAR OR
b 2 2 2 . . . . . . . . . . . .
2 ↔ 2 . . . . . . 1 ↔
. . . . . 2 2 . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . .
OR2 EVAR↔
SURV↔ EVAR↔
2b ↔ ↔ . . . . . . ↔ ↔
. . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . .
. . . . . 2 2b . . . . . . . . . . . .
e
↔
e 2 2 . . . . . . . . . . . .
. . 2 . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . 2 . . . . . .
. . . . . 2 2b ↔ 2 . . . . . .
. . . . . 2b 2 . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . .
. . . . . OR2 EVAR2b
orse than baseline;12, some domains significantly better than baseline,
5D, EuroQol 5-D; EVAR, endovascular aneurysm repair;HS, health status;
nation; NHP, Nottingham Health Profile; NP, data not presented despite
mes Study Short Form (12-item, 20-item, 36-item) Health Survey; SURV,
tter than EVAR scores for 6 of 8 domains.
tality affected more in EVAR).1
EV
2
2
.
.
2
.
.
.
.
↔
.
.
.
.
.
.
antly w
e; EQ-
Exami
Outco
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e.easons for worse pain scores after EVAR in these studies
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Volume 56, Number 2 Peach et al 525are unclear, though greater use of opioid analgesics by OR
patients in the days after surgery may have obscured the
true picture. However, EVAR patients still reported worse
pain 1 month postprocedure, suggesting that this cannot
be the sole explanation. Another possibility is that patients
reported pain in the context of their preoperative expecta-
tions; that is, the OR patients expected to feel postoperative
pain and therefore reported any pain as relatively mild,
whereas those undergoing EVAR did not.
Although there may truly be no differences between
OR and EVAR, those studies that failed to show any
difference between the two groups at this point were gen-
erally small and at high risk of type 2 statistical error. In the
case of Malina et al,22 the absence of a difference between
the two groups may also have been the result of using a
different HS tool (ie, the Nottingham Health Profile).
Although this tool and the SF-36 contain similar domains,
it is thought to be less responsive to changes in social
activity and psychologic status.33
The study by Soulez et al15 also demonstrated the
significance of using different measurement tools. When
pain was assessed using the relevant domains of the SF-36
questionnaire, no significant difference was found between
the two groups. When a more sensitive numeric pain scale
Table II. Continued.
First author HS tool used
3 months
EVAR OR E
Aljabri,172006 SF-36 . . . . . .
Aquino,18 2001 SF-36 . . . . . .
Ballard,19 2004 SF-12 . . . . . .
De Rango,16 2011 SF-36 . . . . . .
EVAR1,9 2005 SF-36, EQ-5D O
EVAR2,8 2005 SF-36, EQ-5D SU
Jones,20 2001 SF-36 . . . . . .
Lederle,10 2009 SF-36, EQ-5D,
IIEF-5
. . . . . .
Lederle,11 2003 SF-36 . . . . . .
Lloyd,21 2000 SF-36, MMSE . . . . . .
Lottman,12 2004 SF-36, EQ-5D ↔ ↔
Malina,22 2000 NHP 1 1
Mangione,23 1997 SF-36 . . . . . .
Perkins,24 1998 SF-36, York QOL . . . 1
Prinssen,14 2004 SF-36, EQ-5D 1 1b
Soulez,15 2005 SF-36, Karnofsky ↔ ↔
UKSAT,13 1998 SF-20 NP NP
Vogel,25 2005 SF-36 OR2 EVAwas used, however, patients who had undergone EVAR 1ad significantly worse pain than those who had been
reated with OR. Similarly, where studies assessedHS using
F-36 and EQ-5D (a less sensitive tool), the results of the
wo tools were not directly conflicting, but EQ-5D often
ailed to detect differences revealed by the SF-36.
Does EVAR affect health status more than OR in
he longer term? Most studies found no significant differ-
nce between EVAR and OR in the long-term, although
here were marked inconsistencies between studies in the
ime taken for HS to return to preoperative levels after AAA
epair, irrespective of the type of intervention. Although
ome showed that HS scores had recovered to baseline (or
etter) within 8 weeks,18,20 others reported decreased
cores as much as 1 year after surgery.14 The reasons for
hese discrepancies are unclear, although it is interesting to
ote that two studies found that scores had returned to
aseline by 3 months postintervention before deteriorating
nce again.14,15 It is possible that by not continuing to
ssess HS once scores had returned to baseline, some
tudies may have missed any second, more prolonged de-
line in HS that might exist.
The late decline in HS post-EVAR demonstrated by
rinssen et al14 was one of the few examples of divergence
f OR and EVAR results 6 months postintervention. At
onths 6 months 1 year 2 years
OR EVAR OR EVAR OR EVAR OR
. . . ↔c ↔c . . . . . . . . . . . .
. . . . . . . . . 1 ↔ . . . . . .
↔ . . . . . . ↔ ↔ . . . . . .
. . . 1 2d . . . . . . 2 2d
EVAR↔ OR↔ EVAR↔
EVAR↔ SURV↔ EVAR↔
. . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . ↔e ↔e ↔e ↔e
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August 2012526 Peach et alEVAR patients in both the physical and psychologic do-
mains. Furthermore, when scores from 12 months post-
EVAR were compared with preoperative scores, emotional
and mental health had improved relative to baseline,
whereas physical function had deteriorated. Although these
findings perhaps support the idea that EVAR patients have
a worse HS than OR patients in the longer term, they also
contradict the suggestion that such a decrease in HS is
caused purely by anxiety or the inconvenience of stent graft
surveillance. Indeed, the relative benefits of OR demon-
strated in this study were achieved despite both groups of
patients having the same postoperative surveillance proto-
col. Aljabri et al17 also found that OR patients had better
physical and general health at 6 months than EVAR pa-
tients. This once again suggests that any difference that
exists between the two groups at this stage is not simply the
result of anxiety.17 The apparent decrease in physical func-
tion at 6 months to 1 year after EVAR could possibly be the
result of reintervention in these patients, although it may
also be due to ongoing symptoms from the original proce-
dure, such as buttock claudication. Unfortunately, this
could not be clarified using generic tools such as the SF-36
or EQ-5D.
As demonstrated here, the predominantly low-quality
studies in this field have failed to clarify the true pattern of
HS in patients with AAA and any changes consequent to
aneurysm repair. Although some of the studies were large,
high-quality, RCT, they only assessed HS as a secondary
end point, and data collection was often over wide intervals
(eg, 3-12 months or 12-24 months) rather than at specific
times. This severely limits the value of their results. Further-
more, most studies that addressed HS as a primary end
point involved very small numbers of patients and provided
only low-level evidence (Table I).
Methodologic differences are exacerbated by the use of
generic HS tools in these studies. Though SF-36 has been
suggested as the most useful tool for assessing QOL in
vascular patients,34 the very varied data presented by the
studies in this review suggest that such generic measures
may be insufficiently sensitive to delineate the changes in
HS associated with AAA repair, especially EVAR. Although
they are well-validated for assessing broad areas of health
status, these tools fail to identify or assess symptoms that
might be directly related to aneurysm repair and, as such,
are unlikely to be truly sensitive to health status changes in
these patients. Important symptoms might include sexual
or gastrointestinal dysfunction, either of which could have
a profound effect on HS or QOL if affected by operative
intervention. Although a number of studies have suggested
that aneurysm repair may result in sexual dysfunction, these
studies have generally been small and retrospective and,
once again, yielded conflicting results.11,35-39 Other symp-
toms, such as decreased appetite, back pain, groin pain, leg
weakness, shortness of breath, and claudication, may also
be relevant, but no validated tool exists to assess these in
this setting.
As surgical practice evolves, HS and QOL are likely to
have increasing significance in relation to screening andarly intervention for AAA. However, the evidence in this
rea is also inconclusive due to the wide intervals at which
ata were collected. Clarification of whether long-term
urveillance or postoperative sequelae have a greater effect
n QOL may help clinicians to determine the optimum
iming for intervention, particularly in relation to small
neurysms detected on screening. Greater understanding
f any QOL differences between OR and EVAR will also
id clinicians and patients in their decision to pursue open
r endovascular repair.
ONCLUSIONS
There are a paucity of quality data relating to HS and
OL in patients with AAA. At present, no clear conclu-
ions can be drawn about the relative QOL benefits of OR
r EVAR, and little is known about the true prevalence of
reoperative or postoperative symptoms and the degree to
hich these influence AAA patients’ well-being. Because
vidence suggests that disease-specific measures are more
esponsive to QOL changes in surgical patients, develop-
ent of a relevant disease-specific tool may help in assessing
hese patients. Whatever the tool used, further work is
eeded to clarify symptoms, HS, and QOL in patients
ndergoing AAA repair. This will identify those issues that
re most important to patients and help clinicians to make
argeted improvements in practice and deliver higher-
uality care.
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